Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
| Autor: | S. Shemes, Patrick Chase, Adina C. Musta, Riad Khatib, Leonard B. Johnson, Jinson Jose, Kathleen Riederer |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Methicillin-Resistant Staphylococcus aureus
Microbiology (medical) Meticillin Genotype Epidemiology Bacteremia Microbial Sensitivity Tests Biology medicine.disease_cause Microbiology medicine Cluster Analysis Humans Etest Antibacterial agent Molecular Epidemiology SCCmec Vancomycin Resistance Chromosomes Bacterial Staphylococcal Infections medicine.disease DNA Fingerprinting Methicillin-resistant Staphylococcus aureus Anti-Bacterial Agents Bacterial Typing Techniques Treatment Outcome Staphylococcus aureus Vancomycin medicine.drug |
| Zdroj: | Journal of Clinical Microbiology. 47:1640-1644 |
| ISSN: | 1098-660X 0095-1137 |
| DOI: | 10.1128/jcm.02135-08 |
| Popis: | Vancomycin MICs (V-MIC) and the frequency of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) isolates are increasing among methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates, but their relevance remains uncertain. We compared the V-MIC (Etest) and the frequency of hVISA (Etest macromethod) for all MRSA blood isolates saved over an 11-year span and correlated the results with the clinical outcome. We tested 489 isolates: 61, 55, 187, and 186 isolates recovered in 1996-1997, 2000, 2002-2003, and 2005-2006, respectively. The V-MICs were ≤1, 1.5, 2, and 3 μg/ml for 74 (15.1%), 355 (72.6%), 50 (10.2%), and 10 (2.1%) isolates, respectively. We detected hVISA in 0/74, 48/355 (13.5%), 15/50 (30.0%), and 8/10 (80.0%) isolates with V-MICs of ≤1, 1.5, 2, and 3 μg/ml, respectively ( P < 0.001). The V-MIC distribution and the hVISA frequency were stable over the 11-year period. Most patients (89.0%) received vancomycin. The mortality rate (evaluated with 285 patients for whose isolates the trough V-MIC was ≥10 μg/ml) was comparable for patients whose isolates had V-MICs of ≤1 and 1.5 μg/ml (19.4% and 27.0%, respectively; P = 0.2) but higher for patients whose isolates had V-MICs of ≥2 μg/ml (47.6%; P = 0.03). However, the impact of V-MIC and hVISA status on mortality or persistent (≥7 days) bacteremia was not substantiated by multivariate analysis. Staphylococcal chromosome cassette mec (SCC mec ) typing of 261 isolates (including all hVISA isolates) revealed that 93.0% of the hVISA isolates were SCC mec type II. These findings demonstrate that the V-MIC distribution and hVISA frequencies were stable over an 11-year span. A V-MIC of ≥2 μg/ml was associated with a higher rate of mortality by univariate analysis, but the relevance of the V-MIC and the presence of hVISA remain uncertain. A multicenter prospective randomized study by the use of standardized methods is needed to evaluate the relevance of hVISA and determine the optimal treatment of patients whose isolates have V-MICs of ≥2.0 μg/ml. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|